Mills Kenneth T.
SEC insider (Form 3/4/5 filer). CIK 0001652824. Director at REGENXBIO Inc. (RGNX). 7 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in ROCKVILLE, MD.
Companies Mills Kenneth T. has filed insider reports for
- REGENXBIO Inc. (RGNX): Director
Mills Kenneth T.
CIK: 0001652824
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (14.3%)
Position reduction
Option Exercises (M)3 (42.9%)
Derivative conversions
Awards (A)2 (28.6%)
Compensation grants
Other (G, F, J, C, D, …)1 (14.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RGNX
REGENXBIO Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 29, 2026RGNX
REGENXBIO Inc.
AwardDirect9.8K shares- - Jan 27, 2026RGNX
REGENXBIO Inc.
ExerciseDirect225K shares at avg. $13.09$2.9M - Jan 27, 2026RGNX
REGENXBIO Inc.
Tax PaymentDirect221.8K shares at avg. $13.41$3.0M - May 30, 2025RGNX
REGENXBIO Inc.
AwardDirect7.8K shares- - May 12, 2025RGNX
REGENXBIO Inc.
ExerciseDirect20.6K shares at avg. $3.76$77K - May 12, 2025RGNX
REGENXBIO Inc.
SaleDirect20.6K shares at avg. $7.91$163K - Mar 27, 2025RGNX
REGENXBIO Inc.
ExerciseDirect30.8K shares at avg. $3.76$116K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 | RGNX REGENXBIO Inc. | Award | 9,807 | - | $0 | Direct |
| Jan 27, 2026 | RGNX REGENXBIO Inc. | Exercise | 225,000 | $13.09 | $2,945,250 | Direct |
| Jan 27, 2026 | RGNX REGENXBIO Inc. | Tax Payment | 221,753 | $13.41 | $2,973,708 | Direct |
| May 30, 2025 | RGNX REGENXBIO Inc. | Award | 7,768 | - | - | Direct |
| May 12, 2025 | RGNX REGENXBIO Inc. | Exercise | 20,602 | $3.76 | $77,464 | Direct |
| May 12, 2025 | RGNX REGENXBIO Inc. | Sale | 20,602 | $7.91 | $163,046 | Direct |
| Mar 27, 2025 | RGNX REGENXBIO Inc. | Exercise | 30,752 | $3.76 | $115,628 | Direct |
1-7 of 7 transactions